A Phase 1, Single-Dose, Open-Label, Crossover Study To Estimate The Relative Bioavailability Of Two Controlled-Release Formulations Vs. An Immediate Release Formulation Of PF-04991532 In Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Jul 2011
At a glance
- Drugs PF 4991532 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 05 Jul 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 13 May 2011 New trial record